Certified by Founder
Lodge
Encord
start up
United States
- San Francisco, California
- 14/08/2024
- Series B
- $30,000,000
Encord is the leading data development platform for advanced vision and multimodal AI teams. We build tools and infrastructure to help our clients get their models into production faster with a data-centric model testing and evaluation framework, human-centric workflow and annotation tools for labeling & RLHF, and data curation and management software.
Encord is trusted by pioneering AI teams at Stanford Medicine, Mass General Brigham, Tractable, Viz AI, Iterative Health, the UHN, the Royal Navy, Veo, and many more global companies.
- Industry Software Development
- Website https://encord.com/
- LinkedIn https://www.linkedin.com/company/encord-team/
TrialClinIQ | $150,000 | (Apr 29, 2026)
Lighthouse Pharmaceuticals | $12,000,000 | (Apr 29, 2026)
Windmill(US) | $12,000,000 | (Apr 29, 2026)
IC Realtime | $2,000,000 | (Apr 29, 2026)
Golden Child | $37,000,000 | (Apr 29, 2026)
Hypervision Surgical | $22,962,410 | (Apr 29, 2026)
dehaze | $3,746,192 | (Apr 29, 2026)
Clarasight | $11,500,000 | (Apr 29, 2026)
Liquid Instruments | $50,000,000 | (Apr 29, 2026)
TriFetch | $1,900,000 | (Apr 28, 2026)
Linexa | $2,342,840 | (Apr 28, 2026)
HrFlow.ai | $7,000,000 | (Apr 28, 2026)